Parquest sells Homeperf to Sapio
Parquest Capital sells homecare specialist Homeperf to Sapio, Italian leader in home care services and medical gases production
Parquest Capital announces the sale of its majority stake in Homeperf, one of the French leaders in homecare services, to Sapio, an Italian group leader in industrial and medical gases production, as well as in homecare serivces. This sale takes place five years after its investment. Over the period, the group has specialized, structured and strengthened itself in an increasingly competitive market to reach 52 million euros of revenues at the end of 2019.
Wishing to continue supporting Homeperf in its new projects, Parquest Capital and its partners (Vivalto ‐ Daniel Caille’s personal holding company ‐, BNP Paribas Développement and Arkéa Capital) are reinvesting by taking a significant minority stake along with Sapio.
Created in 1997 and based in Aix‐en‐Provence, Homeperf is a brand strongly established in France through its national network of 37 agencies and 360 employees. Operating in the homecare market, it specialises in patient treated at home with infusion, artificial nutrition, insulin therapy and respiratory care.
The acquisition of Homeperf represents for Sapio the opportunity to build on a solid base to give a new impetus to its development on the French market and to strengthen its position as an independent European player on the home healthcare market. With a turnover of more than 550 million euros, Sapio employs 1,800 people, 1,000 of whom work in Italy. The group is also present in Germany, France, Spain, Turkey and Slovenia.
Mario Paterlini, CEO of Sapio and new president of Homeperf :
“This acquisition marks a very important step, as France is Europe’s leading home care market, a market that is constantly growing in value. For our growth strategy, it was therefore decisive to strengthen our presence: Homeperf represented a unique development opportunity. I would like to thank the group of investors who made this operation possible. Our goal now is to become one of the leading national players, with a strong brand, highly qualified staff, an extensive presence in the territory and an excellent reputation.”
Recognized expertise in the health sector
This sale, which comes a few months after the sale of Groupe 5 Santé to Korian, illustrates Parquest Capital’s expertise in the healthcare sector. Its team is recognized for its expertise in this sector, with nearly 15 years of experience in supporting the development of companies that have become leaders
in their markets, particularly in the field of healthcare services, both at home and in institutions, with success stories such as Vivalto Santé, Unither Pharmaceuticals, Homeperf and the 5 Santé group of private clinics and follow‐up care.
“We have been very pleased to support Homeperf’s development over these five years in an activity that today more than ever demonstrates its importance and a sector in which Parquest Capital has made a major strategic focus. The company’s success story, which began more than twenty years ago,
will be able to continue and accelerate with an industrial partner who will give it the means to take it to the next level”, says Denis Le Chevallier, Managing Partner of Parquest Capital.
